fda warning letters compounded semaglutide october 2025 telehealth crackdown highlights role of national doctor networks July 29, 2024: FDA issued

Only 11.2 percent of such patients received a GLP-1 prescription, 6.3 percent received behavioural health services and 0.28 percent had bariatric surgery

It is safest to take FDA-approved brand-name products (Ozempic, Wegovy, Rybelsus) made by Novo Nordisk

While prevalence of type 1 diabetes is higher in first-degree relatives of people with type 1 diabetes (6% vs 0.4% in the general population), 85% of people diagnosed with type 1 diabetes do not have a first-degree relative with the disease

A real-world study looking at how people respond outside of clinical trials found that non-response rates may be somewhat higher in everyday practice, with 10 to 30% of patients achieving less than 5% total body weight loss, depending on the dose and individual factors involved (4)

Under federal law, payments to Medicaid MCOs must be actuarially sound

Differential effects of neonatal and adult androgen exposure on the growth hormone secretory pattern in male rats